Search by Drug Name or NDC

    NDC 47781-0595-07 Paclitaxel 300 mg/50mL Details

    Paclitaxel 300 mg/50mL

    Paclitaxel is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Alvogen Inc.. The primary component is PACLITAXEL.

    Product Information

    NDC 47781-0595
    Product ID 47781-595_069e086b-1cd0-f698-c6f0-3335b7a60f2f
    Associated GPIs 21500012001350
    GCN Sequence Number 046997
    GCN Sequence Number Description paclitaxel VIAL 6 MG/ML INTRAVEN
    HIC3 V1F
    HIC3 Description ANTINEOPLASTICS,MISCELLANEOUS
    GCN 85602
    HICL Sequence Number 007625
    HICL Sequence Number Description PACLITAXEL
    Brand/Generic Generic
    Proprietary Name Paclitaxel
    Proprietary Name Suffix n/a
    Non-Proprietary Name paclitaxel
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 300
    Active Ingredient Units mg/50mL
    Substance Name PACLITAXEL
    Labeler Name Alvogen Inc.
    Pharmaceutical Class Microtubule Inhibition [PE], Microtubule Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207326
    Listing Certified Through 2024-12-31

    Package

    NDC 47781-0595-07 (47781059507)

    NDC Package Code 47781-595-07
    Billing NDC 47781059507
    Package 1 VIAL, MULTI-DOSE in 1 CARTON (47781-595-07) / 50 mL in 1 VIAL, MULTI-DOSE
    Marketing Start Date 2017-12-27
    NDC Exclude Flag N
    Pricing Information N/A